James McAuley
@james-mcauley.bsky.social
Reposted by James McAuley
@james-mcauley.bsky.social @miguelhernan.org @lizstuart.bsky.social @margaritamb.bsky.social @sharpmelk.bsky.social and everyone who isn't on Bluesky - Aidan, Sonja, Matt, Hopin, Matthias, Jonathan, Barbra, Xabier, Rob, Sara, Sallie, Sebastian, and Issa
September 3, 2025 at 9:06 PM
@james-mcauley.bsky.social @miguelhernan.org @lizstuart.bsky.social @margaritamb.bsky.social @sharpmelk.bsky.social and everyone who isn't on Bluesky - Aidan, Sonja, Matt, Hopin, Matthias, Jonathan, Barbra, Xabier, Rob, Sara, Sallie, Sebastian, and Issa
Is medical practice ahead of the evidence?
Out today 🚨 Our Cochrane review of 67 RCTs finds no clear evidence of benefit for ketamine or other NMDA antagonists for chronic pain. IV ketamine associated with risk of psychotomimetic effects, nausea, and vomiting. doi.org/10.1002/1465...
Ketamine and other NMDA receptor antagonists for chronic pain - Ferraro, MC - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
doi.org
August 21, 2025 at 2:56 AM
Is medical practice ahead of the evidence?